Overall, when a unique or ultra-rare ambiguous GLA variant is identified in the absence of other LP/P variants in the same gene and variant- and gene-level data are insufficient to resolve the uncertainty, a GB3-positive tissue biopsy can meet the PS3 pathogenic criterion, providing an unambiguous diagnosis of AFD. The gene discussed is TAS2R6P; the disease is Nager acrofacial dysostosis.